ReCODE
Clinical Trial 2019.
The first clinical trial
We are thrilled to be working on Dr. Bredesen’s first clinical trial for the prevention and reversal of cognitive decline using his precision medicine ReCODE protocol. Details of the study can be found here: https://clinicaltrials.gov/ct2/show/NCT03883633
The study will span a nine-month period with three study sites and 30 participants. We will be working one-on-one with 10 of the study participants for the duration of the study to help participants understand what’s expected of them, help them adopt the protocol lifestyle, facilitate behavior change, and comply with the study requirements.
Study participants are provided with the support they need to be successul and to maintain the lifestyle changes beyond the study.
Results of the study can be found here: https://www.apollohealthco.com/alzheimers-reversal/
If you are interested in learning more about the ReCODE protolcol, click the button below to set up a free consultation.
“Signs of the characteristic amyloid plaques found in Alzheimer’s brains can sometimes be found in the brains of healthy people as young as 20 years old.”